{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:57:11Z","timestamp":1775843831337,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Acute leukemia (AL) is characterized by excessive proliferation and impaired differentiation of leukemic cells. AL includes acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Previous studies have demonstrated that about 10% of AML and 22% of ALL are mixed lineage leukemia gene rearrangements (MLLr) leukemia. The prognosis of MLLr leukemia is poor and new therapeutics are urgently needed. Differentiation therapy with all-trans-retinoic acid (ATRA) has prolonged the 5-years disease-free survival rate in acute promyelocytic leukemia (APL), a subtype of AML. However, the differentiation therapy has not been effective in other acute leukemia. Here, we aim to explore the cell differentiation effect of the potent HDACs inhibitor, I1, and the possible mechanism on the MLLr-AML and MLLr-ALL cells (MOLM-13, THP-1, MV4-11 and SEM). It is shown that I1 can significantly inhibit the proliferation and the colony-forming ability of MOLM-13, THP-1, MV4-11 and SEM cells by promoting cell differentiation coupled with cell cycle block at G0\/G1 phase. We show that the anti-proliferative effect of I1 attributed to cell differentiation is most likely associated with the HDAC inhibition activity, as assessed by the acetylation of histone H3 and H4, which may dictates the activation of hematopoietic cell lineage pathway in both MOLM-13 and THP-1 cell lines. Moreover, the activity of HDAC inhibition of I1 is stronger than that of SAHA in MOLM-13 and THP-1 cells. Our findings suggest that I1, as a chromatin-remodeling agent, could be a potent epigenetic drug to overcome differentiation block in MLLr-AL patients and would be promising for the treatment of AL.<\/jats:p>","DOI":"10.3389\/fphar.2022.876076","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T04:54:40Z","timestamp":1651035280000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements via Epigenetic Modification"],"prefix":"10.3389","volume":"13","author":[{"given":"Jingfang","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gentao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peilei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuya","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"B1","first-page":"141","article-title":"Immunotherapy and Acute Lymphoblastic Leukemia","volume":"2","author":"Allen","year":"2016","journal-title":"EC Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","article-title":"Novel Prognostic Subgroups in Childhood 11q23\/MLL-Rearranged Acute Myeloid Leukemia: Results of an International Retrospective Study","volume":"114","author":"Balgobind","year":"2009","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1158\/0008-5472.CAN-04-3011","article-title":"Valproic Acid Stimulates Proliferation and Self-Renewal of Hematopoietic Stem Cells","volume":"65","author":"Bug","year":"2005","journal-title":"Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/14756366.2020.1870457","article-title":"Discovery of Indole-3-Butyric Acid Derivatives as Potent Histone Deacetylase Inhibitors","volume":"36","author":"Chen","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1158\/0008-5472.CAN-04-3063","article-title":"Histone Deacetylase Inhibitor Valproic Acid Enhances the Cytokine-Induced Expansion of Human Hematopoietic Stem Cells","volume":"65","author":"De Felice","year":"2005","journal-title":"Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood.V97.12.3925","article-title":"Detection of Leukemic Cells in the Cd34(+)cd38(-) Bone Marrow Progenitor Population in Children with Acute Lymphoblastic Leukemia","volume":"97","author":"George","year":"2001","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fcell.2015.00041","article-title":"Leukemogenic Rearrangements at the Mixed Lineage Leukemia Gene (MLL)-multiple rather Than a Single Mechanism","volume":"3","author":"Gole","year":"2015","journal-title":"Front. Cel Dev. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic Acid Defines a Novel Class of HDAC Inhibitors Inducing Differentiation of Transformed Cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone-deacetylase Inhibitors: Novel Drugs for the Treatment of Cancer","volume":"1","author":"Johnstone","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"B10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00129039-200109000-00007","article-title":"Antigenic Characterization of Medullary Carcinoma of the Breast: HLA-DR Expression in Lymph Node Positive Cases","volume":"9","author":"Lazzaro","year":"2001","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41420-021-00472-6","article-title":"Histone Modifications Centric-Regulation in Osteogenic Differentiation","volume":"7","author":"Li","year":"2021","journal-title":"Cell Death Discov."},{"key":"B12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bioorg.2016.05.005","article-title":"Inhibitors of Histone Deacetylase as Antitumor Agents: A Critical Review","volume":"67","author":"Manal","year":"2016","journal-title":"Bioorg. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/cancers11030304","article-title":"Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy","volume":"11","author":"Manzotti","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ardp.201400449","article-title":"MLL Leukemia and Future Treatment Strategies","volume":"348","author":"Marschalek","year":"2015","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1182\/blood-2003-07-2431","article-title":"Modification of Hematopoietic Stem Cell Fate by 5aza 2'deoxycytidine and Trichostatin A","volume":"103","author":"Milhem","year":"2004","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nm1161","article-title":"Tumor-selective Action of HDAC Inhibitors Involves TRAIL Induction in Acute Myeloid Leukemia Cells","volume":"11","author":"Nebbioso","year":"2005","journal-title":"Nat. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1200\/JCO.2005.01.9679","article-title":"Clinical Experience with Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Patients with Advanced Hematologic Malignancies","volume":"24","author":"O'Connor","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1038\/onc.2016.488","article-title":"MLL-AF9 and MLL-AF4 Oncofusion Proteins Bind a Distinct Enhancer Repertoire and Target the RUNX1 Program in 11q23 Acute Myeloid Leukemia","volume":"36","author":"Prange","year":"2017","journal-title":"Oncogene"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of Treatment in Childhood Acute Lymphoblastic Leukaemia with Rearrangements of the 11q23 Chromosomal Region","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1109\/APS.1989.134877","article-title":"The Histone Deacetylase Inhibitor MS-275 Promotes Differentiation or Apoptosis in Human Leukemia Cells through a Process Regulated by Generation of Reactive Oxygen Species and Induction of p21CIP1\/WAF1 1","volume":"63","author":"Rosato","year":"2003","journal-title":"Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1182\/blood-2003-02-0434","article-title":"AML with 11q23\/MLL Abnormalities as Defined by the WHO Classification: Incidence, Partner Chromosomes, FAB Subtype, Age Distribution, and Prognostic Impact in an Unselected Series of 1897 Cytogenetically Analyzed AML Cases","volume":"102","author":"Schoch","year":"2003","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1470-2045(09)70369-9","article-title":"Genetic Aberrations in Paediatric Acute Leukaemias and Implications for Management of Patients","volume":"11","author":"Szczepa\u0144ski","year":"2010","journal-title":"Lancet Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc989","article-title":"Disruption of Differentiation in Human Cancer: AML Shows the Way","volume":"3","author":"Tenen","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1038\/onc.2013.411","article-title":"Targeting Cancer Stem Cells to Suppress Acquired Chemotherapy Resistance","volume":"33","author":"Vidal","year":"2014","journal-title":"Oncogene"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute Promyelocytic Leukemia: from Highly Fatal to Highly Curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"B26","first-page":"267","article-title":"Histone Deacetylase Inhibitor SAHA Induces Inactivation of MAPK Signaling and Apoptosis in HL-60 Cells","volume":"15","author":"Wang","year":"2007","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"B27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and Emerging HDAC Inhibitors for Cancer Treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/sj.leu.2401840","article-title":"Detection of Acute Leukemia Cells with Mixed Lineage Leukemia (MLL) Gene Rearrangements by Flow Cytometry Using Monoclonal Antibody 7.1","volume":"14","author":"Wuchter","year":"2000","journal-title":"Leukemia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ijc.32552","article-title":"Small Molecular Modulators of Jmjd1c Preferentially Inhibit Growth of Leukemia Cells","volume":"146","author":"Xu","year":"2020","journal-title":"Int. J. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1158\/0008-5472.CAN-15-1616","article-title":"Natural Product Vibsanin a Induces Differentiation of Myeloid Leukemia Cells through Pkc Activation","volume":"76","author":"Yu","year":"2016","journal-title":"Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/leu.2008.141","article-title":"Epigenetic Plasticity of Chromatin in Embryonic and Hematopoietic Stem\/progenitor Cells: Therapeutic Potential of Cell Reprogramming","volume":"22","author":"Zardo","year":"2008","journal-title":"Leukemia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"13991","DOI":"10.1038\/s41598-017-14451-4","article-title":"Expression and Regulation of Long Noncoding RNAs during the Osteogenic Differentiation of Periodontal Ligament Stem Cells in the Inflammatory Microenvironment","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.876076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T04:54:44Z","timestamp":1651035284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.876076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":32,"alternative-id":["10.3389\/fphar.2022.876076"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.876076","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"article-number":"876076"}}